Cayman Islands, January 29, 2025 -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi ...
Silexion Therapeutics Corp. (SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today ...
What is the current share price of Silexion Therapeutics Corp (SLXN)? Silexion Therapeutics Corp's (SLXN) current share price is $1.08. This constitutes a price movement of 14.29% when compared to the ...
Sustainability data is currently unavailable for SLXNW.
After hours: 7:57:20 p.m. EST ...
After hours: February 14 at 7:57:20 p.m. EST ...
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United ...
Foxx Development Holdings Inc. operates as a consumer electronics and integrated internet-of-things (IoT) solution company in the United States. The company offers smartphones, tablets, wearables ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback